title: Piracetam preparations on the Belgian market: a comparative study.
abstract: Piracetam preparations formulated as capsules, tablets and granules were evaluated with different tests including in vitro dissolution and assay with previously validated methods according to the guideline of the European network of official medicines control laboratories (OMCLs). All examined products complied with the requirements as described here and in the European Pharmacopoeia except for the dissolution test where 3 products did not meet the USP acceptance criteria applied on the established specification.
authors.affiliation: Service de Contrôle des Médicaments, rue Stévin 137, B-1000 Bruxelles.
authors.forename: J
authors.initials: J
authors.lastname: Saevels
authors.forename: K
authors.initials: K
authors.lastname: De Braekeleer
authors.forename: J
authors.initials: J
authors.lastname: Corthout
mesh_terms: D001530:Belgium; D002853:Chromatography, Liquid; D018696:Neuroprotective Agents / Q000008:administration & dosage* / Q000737:chemistry*; D010889:Piracetam / Q000008:administration & dosage* / Q000737:chemistry*; D015203:Reproducibility of Results; D012995:Solubility
chemical_list: D018696:Neuroprotective Agents; D010889:Piracetam